BALVERSA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Estonia, Finland, France, Hong Kong SAR China, Israel, Italy, Lithuania, Romania, Turkey, UK.

Active ingredients

The drug BALVERSA contains one active pharmaceutical ingredient (API):

1	Erdafitinib UNII 890E37NHMV - ERDAFITINIB
	Erdafitinib is a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor. Erdafitinib increases serum phosphate concentration, a secondary effect of FGFR inhibition.
	Read more about Erdafitinib

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BALVERSA Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01EN01	Erdafitinib	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
Discover more medicines within L01EN01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02493217, 02493225, 02493233
EE	Ravimiamet	3089112, 3089224, 3089235, 3089246, 3089257, 3089268, 3089279, 3089280, 3089358, 3089415, 3089448
FI	Lääkealan turvallisuus- ja kehittämiskeskus	415130, 442428, 454312
FR	Base de données publique des médicaments	60039171, 65760218, 66039107
HK	Department of Health Drug Office	66726, 66727, 66728
IL	מִשְׂרַד הַבְּרִיאוּת	8488, 8489, 8490, 8491, 8492
IT	Agenzia del Farmaco	051462012, 051462024, 051462036, 051462048, 051462051, 051462063, 051462075, 051462087, 051462099, 051462101, 051462113
LT	Valstybinė vaistų kontrolės tarnyba	1100941, 1100942, 1100943, 1100944, 1100945, 1100946, 1100947, 1100948, 1100949, 1100950, 1100951
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W70738001, W70738002, W70738003, W70738004, W70739001, W70739002, W70739003, W70739004, W70739005, W70740001, W70740002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593095627, 8699593095634, 8699593095641, 8699593095658, 8699593095665
US	FDA, National Drug Code	59676-030, 59676-040, 59676-050